BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19903374)

  • 1. Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice.
    Mohapatra J; Sharma M; Singh S; Pandya G; Chatterjee A; Balaraman R; Patel PR; Jain MR
    J Pharm Pharmacol; 2009 Nov; 61(11):1493-8. PubMed ID: 19903374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet.
    Zhang W; Liu CQ; Wang PW; Sun SY; Su WJ; Zhang HJ; Li XJ; Yang SY
    Eur J Pharmacol; 2010 Dec; 649(1-3):398-402. PubMed ID: 20869961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
    Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
    Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG
    Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice.
    Chang HP; Wang ML; Chan MH; Chiu YS; Chen YH
    Nutrition; 2011 Apr; 27(4):463-70. PubMed ID: 21392705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
    Miranville A; Herling AW; Biemer-Daub G; Voss MD
    Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice.
    Migrenne S; Lacombe A; Lefèvre AL; Pruniaux MP; Guillot E; Galzin AM; Magnan C
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R929-35. PubMed ID: 19211723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice.
    Verty AN; Lockie SH; Stefanidis A; Oldfield BJ
    Int J Obes (Lond); 2013 Feb; 37(2):279-87. PubMed ID: 22473329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity.
    Wang Q; Perrard XD; Perrard JL; Mansoori A; Smith CW; Ballantyne CM; Wu H
    Obesity (Silver Spring); 2011 Mar; 19(3):505-13. PubMed ID: 20885384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
    Ge Q; Maury E; Rycken L; Gérard J; Noël L; Detry R; Navez B; Brichard SM
    Int J Obes (Lond); 2013 Jun; 37(6):874-80. PubMed ID: 22868830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.
    Poirier B; Bidouard JP; Cadrouvele C; Marniquet X; Staels B; O'Connor SE; Janiak P; Herbert JM
    Diabetes Obes Metab; 2005 Jan; 7(1):65-72. PubMed ID: 15642077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
    Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.
    Chen W; Chen Z; Xue N; Zheng Z; Li S; Wang L
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):721-32. PubMed ID: 23620336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
    Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
    Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
    Irwin N; Hunter K; Frizzell N; Flatt PR
    Eur J Pharmacol; 2008 Feb; 581(1-2):226-33. PubMed ID: 18191122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.
    Bell-Anderson KS; Aouad L; Williams H; Sanz FR; Phuyal J; Larter CZ; Farrell GC; Caterson ID
    Int J Obes (Lond); 2011 Dec; 35(12):1539-48. PubMed ID: 21386801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.